Controlled-release nanoparticulate compositions
作者： Janet Elizabeth Codd , Maurice Joseph Anthony Clancy , Jon Swanson , Robert Hontz , Kenneth Iain Cumming
DOI:
关键词:
摘要: Described are controlled release nanoparticulate formulations comprising a agent to be administered and rate-controlling polymer which functions prolong the of following administration. The novel compositions administration for time period ranging from about two twenty four hours or longer.
google.co.uk 参考文章(150)
Takahiro Matsumoto, George Zografi, Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharmaceutical Research. ,vol. 16, pp. 1722- 1728 ,(1999) , 10.1023/A:1018906132279
Ramesh N. Acharya, Calcium polycarbophil-alginate controlled release composition and method ,(1990)
Johan Carlfors, Irena Blute, Bengt Kronberg, Brita Sjöström, A process for the preparation of drug particles ,(1990)
D. Philip Cords, Patrick H. Fitzgerald, Charles R. Clark, Nicholas O. Wolf, Emulsion breaking using alkylphenol-polyethylene oxide-acrylate polymer coated coalescer material ,(1992)
Edward Penley Abraham, Some properties of egg-white lysozyme. Biochemical Journal. ,vol. 33, pp. 622- 630 ,(1939) , 10.1042/BJ0330622
Lan De Castro, Method of preparing stable drug nanoparticles ,(1995)
Preston John Miles, Stabilized phosphoric acid ,(1964)
Thinnayam N. Krishnamurthy, Controlled release matrix suppository for pharmaceuticals ,(1991)
David S. Holmes, Ahmed S. Mughal, Slow release pharmaceutical composition ,(1982)